WEST PHARMACEUTICAL SERVICES INC — Director's Dealing 2009

Jul 22, 2009

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: WEST PHARMACEUTICAL SERVICES INC (WST)
CIK: 0000105770
Period of Report: 2009-07-14

Reporting Person: Van Dijk Ronald (President Asia Pacific)

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	7451.685	Direct

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Stock Appreciate Right	$32.09	2019-02-24	Common Stock (2500)		Direct
Stock Appreciate Right	$32.585	2016-02-24	Common Stock (3094)		Direct
Stock Appreciate Right	$41.7	2018-02-26	Common Stock (2750)		Direct
Stock Appreciate Right	$44.97	2017-02-27	Common Stock (2634)		Direct
Stock Option (Right to Buy)	$19.365	2014-05-05	Common Stock (2700)		Direct
Stock Option (Right to Buy)	$25.53	2015-03-05	Common Stock (3000)		Direct

Footnotes

F1: These grants vests in 4 equal annual installments beginning on first anniversary of the grant and expire 10 years from the grant date.